Viridian Therapeutics, Inc. (0K1R.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.64B |
| Enterprise Value | 2.48B |
| P/E Ratio | -5.67 |
| PEG Ratio | -1.29 |
| Price/Sales Ratio | 25.05 |
| Price/Book Ratio | 3.17 |
| Enterprise/Revenue | 23.29 |
| Enterprise/EBITDA | -4.73 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -5.08 |
| Operating Margin | -5.44 |
AD
Management Effectiveness
| Return On Assets | -0.46 |
| Return On Equity | -0.61 |
Income Statement
| Revenue | 70.85M |
| Revenue/Share | 0.69 |
| Gross Profit | 69.69M |
| EBITDA | -362.24M |
| Net Income | -342.6M |
| Diluted EPS | -3.32 |
Balance Sheet
| Total Cash | 762.18M |
| Total Cash/Share | 7.46 |
| Total Debt | 53.35M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 15.15 |
| Book Value Per Share | 6.22 |
Price History
| 52-Week Change | 15.59 |
| 52-Week High | 29.3 |
| 52-Week Low | 10.98 |
| Moving Average 50 Days | 20.02 |
| Moving Average 200 Days | 19.53 |
Statistics
| Average Volume | 682 |
| Shares Outstanding | 90M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | September 21, 2021 |
AD
